The Discounted Cash Flow (DCF) valuation of Neogenomics Inc (NEO) is (12.87) USD. With the latest stock price at 11.68 USD, the upside of Neogenomics Inc based on DCF is -210.2%.
Based on the latest price of 11.68 USD and our DCF valuation, Neogenomics Inc (NEO) is a sell. selling NEO stocks now will result in a potential gain of 210.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 9.2% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (42.42) - (8.37) | (12.87) |
| Upside | -463.2% - -171.6% | -210.2% |